Skip to main content
. 2018 Feb 19;9:72. doi: 10.3389/fneur.2018.00072

Table 3.

Hormonal disorders and self-report questionnaire percentiles for individual participants who screened positive for hypopituitarism.

Identifiers Deficiency PCL-M NSI PHQ-9 PSQI AUDIT-C
Mild traumatic brain injuries (mTBI)-A GHD 98 92 98 90 22
mTBI-B GHD 82 88 83 97 85
mTBI-C Diabetes insipidus (DI) 55 56 38 97 5
mTBI-D Hypothyroidism, DI 94 97 98 57 85
mTBI-E GHD, hypogonadism, hyperprolactinemia 78 69 72 NS 38
mTBI-F Hypothyroidism 98 99 98 35 11
mTBI-G Hypogonadism 98 99 97 87 99
mTBI-H Hypooxytocinemia 74 60 53 29 56
mTBI-I GHD 49 39 29 23 11
mTBI-J GHD 18 45 25 23 72
mTBI-K DI 51 35 21 87 93
mTBI-L GHD, hypooxytocinemia 22 22 14 23 97
DC-A GHD 57 37 58 57 56
DC-B GHD 10 12 14 5 56
DC-C Hyperprolactinemia 53 41 58 64 11

Percentile is based on the ranking of all participants. The higher the percentile, the more severe or frequent the symptoms endorsed. The participant identifiers in the far-left column are “dummy” identifiers and are not the participant identification sequences used in the study. Percentile values falling in the highest (fourth) quartile of scores are highlighted in yellow.

GHD, growth hormone deficiency; PCL-M, Posttraumatic Stress Disorder CheckList-Military; NSI, Neurobehavioral Symptom Inventory; PHQ-9, Patient Health Questionnaire-9; PSQI, Pittsburgh Sleep Quality Index; AUDIT-C, Alcohol Use Disorders Identification Test-Consumption; NS, no score.